These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8034505)

  • 21. Clinical use of fluoroquinolones in children.
    Alghasham AA; Nahata MC
    Ann Pharmacother; 2000 Mar; 34(3):347-59; quiz 413-4. PubMed ID: 10917383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetics of ciprofloxacin in pediatric patients.
    Rajagopalan P; Gastonguay MR
    J Clin Pharmacol; 2003 Jul; 43(7):698-710. PubMed ID: 12856383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The efficacy and safety of ciprofloxacin in treating children with mucoviscidosis].
    Postnikov SS; Semykin SIu; Kapranov NI; Perederko LV; Polikarpova SV
    Antibiot Khimioter; 2000; 45(4):14-7. PubMed ID: 10851644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin treatment in preterm neonates in Bangladesh: lack of effects on growth and development.
    Ahmed AS; Khan NZ; Saha SK; Chowdhury MA; Muslima H; Law P; Islam M; Bhattacharya M; Darmstadt GL
    Pediatr Infect Dis J; 2006 Dec; 25(12):1137-41. PubMed ID: 17133159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use--safety report.
    Hampel B; Hullmann R; Schmidt H
    Pediatr Infect Dis J; 1997 Jan; 16(1):127-9; discussion 160-2. PubMed ID: 9002122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the new quinolones during pregnancy.
    Koren G
    Can Fam Physician; 1996 Jun; 42():1097-9. PubMed ID: 8704483
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fluoroquinolones in children].
    Gendrel D
    Med Trop (Mars); 2002; 62(2):185-92. PubMed ID: 12192718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative yearly growth rate of children with mucoviscidosis treated and not treated with ciprofloxacin:clinicomorphological comparisons].
    Postnikov CC; Semiakin SI; Nazhimov VP; Kapranov NI
    Antibiot Khimioter; 2001; 46(10):11-3. PubMed ID: 11881187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe.
    Ferech M; Coenen S; Malhotra-Kumar S; Dvorakova K; Hendrickx E; Suetens C; Goossens H;
    J Antimicrob Chemother; 2006 Aug; 58(2):423-7. PubMed ID: 16735418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new respiratory fluoroquinolone, oral gemifloxacin: a safety profile in context.
    Ball P; Mandell L; Patou G; Dankner W; Tillotson G
    Int J Antimicrob Agents; 2004 May; 23(5):421-9. PubMed ID: 15120718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of quinolones in pediatric patients.
    Adam D
    Rev Infect Dis; 1989; 11 Suppl 5():S1113-6. PubMed ID: 2672245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An audit of ciprofloxacin use in severe life threatening infection at the AKUH.
    Abdulla AM
    J Pak Med Assoc; 1996 Jan; 46(1):25-7. PubMed ID: 8830166
    [No Abstract]   [Full Text] [Related]  

  • 35. Ciprofloxacin in multi-resistant infections in childhood: an audit.
    Khan DM; Bhutta ZA
    J Pak Med Assoc; 1995 Jun; 45(6):147-50. PubMed ID: 7474287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinolones: a new class of antimicrobial agents with wide potential uses.
    Neu HC
    Med Clin North Am; 1988 May; 72(3):623-36. PubMed ID: 3280910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A new quinolone (pefloxacine) in bronchopulmonary superinfections in cystic fibrosis].
    Reineri P; Squinazi F; Tobelem R; Lemerle S; Lobut JB; Bernaudin F; Kohout G; Bouveret
    Pediatrie; 1984; 39(7):597-8. PubMed ID: 6598489
    [No Abstract]   [Full Text] [Related]  

  • 38. [Advances in pharmacokinetic studies and clinical use of antibiotics and various chemotherapeutic agents in children].
    Prandota J; Sarul H
    Pediatr Pol; 1988 Jun; 63(6):397-404. PubMed ID: 3070476
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of the new quinolones in cystic fibrosis.
    Grenier B
    Rev Infect Dis; 1989; 11 Suppl 5():S1245-52. PubMed ID: 2672252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quinolones in children. Are concerns over arthropathy justified?
    Stahlmann R; Förster C; Van Sickle D
    Drug Saf; 1993 Dec; 9(6):397-403. PubMed ID: 8129861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.